FDA Approves Potentially Groundbreaking Schizophrenia Drug

7 months ago 62

Cobenfy

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.